Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Summary

Subjects stable on L-Dopa and oral ropinirole will have their ropinirole replaced with the Ropinirole Implant(s). The Ropinirole Implant was designed using the ProNeura™ implant technology where the implant is inserted under the skin. This study will measure how much ropinirole is released in the blood during 12 weeks of ropinirole implant treatment, and evaluate the side effects of this new formulation.

Timeline

Start

2017-10-10

Primary completion

2018-05-22

Completion

2018-05-22

Outcome

Outcome not reported

Stopped: “This study was terminated for reasons not related to efficacy or safety”

Drugs

Indications